Combining mathematical modeling and deep learning to make rapid and explainable predictions of the patient-specific response to anticoagulant therapy under venous flow.
Anticoagulant
Blood coagulation
Computational fluid dynamics
Personalized medicine
Support vector machines
Journal
Mathematical biosciences
ISSN: 1879-3134
Titre abrégé: Math Biosci
Pays: United States
ID NLM: 0103146
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
25
09
2021
revised:
19
04
2022
accepted:
21
04
2022
pubmed:
4
5
2022
medline:
16
6
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
Anticoagulant drugs are commonly prescribed to prevent hypercoagulable states in patients with venous thromboembolism. The choice of the most efficient anticoagulant and the appropriate dosage regimen remain a complex problem because of the intersubject variability in the coagulation kinetics and the effect of blood flow. The rapid assessment of the patient-specific response to anticoagulant regimens would assist clinical decision-making and ensure efficient management of coagulopathy. In this work, we introduce a novel approach that combines computational modeling and deep learning for the fast prediction of the patient-specific response to anticoagulant regimens. We extend a previously developed model to explore the spatio-temporal dynamics of thrombin generation and thrombus formation under anticoagulation therapy. Using a 1D version of the model, we generate a dataset of thrombus formation for thousands of virtual patients by varying key parameters in their physiological range. We use this dataset to train an artificial neural network (ANN) and we use it to predict patient's response to anticoagulant therapy under flow. The algorithm is available and can be accessed through the link: https://github.com/MPS7/ML_coag. It yields an accuracy of 96 % which suggests that its usefulness can be assessed in a randomized clinical trial. The exploration of the model dynamics explains the decisions taken by the algorithm.
Identifiants
pubmed: 35504312
pii: S0025-5564(22)00038-4
doi: 10.1016/j.mbs.2022.108830
pii:
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108830Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.